2022 Q4 Form 10-Q Financial Statement

#000149315222032038 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $6.366M $1.707M $4.136M
YoY Change 37.7% -58.73% 65.44%
Cost Of Revenue $5.960M $1.954M $3.170M
YoY Change 95.22% -38.36% -39.04%
Gross Profit $406.0K -$247.0K $966.0K
YoY Change -74.14% -125.57% -135.78%
Gross Profit Margin 6.38% -14.47% 23.36%
Selling, General & Admin $1.465M $1.810M $1.195M
YoY Change 128.19% 51.46% -21.9%
% of Gross Profit 360.84% 123.71%
Research & Development $315.0K $319.0K $533.0K
YoY Change -37.13% -40.15% 8.78%
% of Gross Profit 77.59% 55.18%
Depreciation & Amortization $120.0K $124.0K $133.0K
YoY Change -6.98% -6.77% -16.87%
% of Gross Profit 29.56% 13.77%
Operating Expenses $1.731M $2.129M $1.728M
YoY Change 51.44% 23.21% -14.03%
Operating Profit -$1.325M -$2.376M -$762.0K
YoY Change -410.3% 211.81% -83.82%
Interest Expense -$19.00K $12.00K -$14.00K
YoY Change 35.71% -185.71% 40.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$5.000K $3.000K
YoY Change -266.67%
Pretax Income -$1.344M -$2.381M $942.0K
YoY Change -425.42% -352.76% -119.96%
Income Tax
% Of Pretax Income
Net Earnings -$1.344M -$2.381M $942.0K
YoY Change -425.42% -352.76% -119.96%
Net Earnings / Revenue -21.11% -139.48% 22.78%
Basic Earnings Per Share -$0.19 $0.07
Diluted Earnings Per Share -$0.11 -$0.19 $73.55K
COMMON SHARES
Basic Shares Outstanding 12.95M shares 12.79M shares 12.79M shares
Diluted Shares Outstanding 12.85M shares 12.81M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $211.0K $363.0K $7.706M
YoY Change -95.86% -95.29% 272.27%
Cash & Equivalents $211.0K $363.0K $7.706M
Short-Term Investments
Other Short-Term Assets $4.629M $6.328M $4.116M
YoY Change -22.93% 53.74% 1147.27%
Inventory $15.46M $15.63M $8.598M
Prepaid Expenses $2.629M $4.328M
Receivables $2.230M $1.216M $3.520M
Other Receivables $787.0K $787.0K $787.0K
Total Short-Term Assets $23.32M $24.32M $24.73M
YoY Change -7.3% -1.65% 43.1%
LONG-TERM ASSETS
Property, Plant & Equipment $538.0K $657.0K $2.170M
YoY Change -47.2% -69.72% -35.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $93.00K $93.00K $94.00K
YoY Change 0.0% -1.06% -87.47%
Total Long-Term Assets $871.0K $1.161M $2.264M
YoY Change -57.01% -48.72% -44.78%
TOTAL ASSETS
Total Short-Term Assets $23.32M $24.32M $24.73M
Total Long-Term Assets $871.0K $1.161M $2.264M
Total Assets $24.19M $25.48M $26.99M
YoY Change -11.01% -5.6% 26.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $230.0K $425.0K $209.0K
YoY Change -29.88% 103.35% -34.69%
Accrued Expenses $1.499M $1.632M $1.960M
YoY Change -22.21% -16.73% 24.84%
Deferred Revenue
YoY Change
Short-Term Debt $1.884M $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $211.0K $248.0K $240.0K
YoY Change -12.81% 3.33% -17.24%
Total Short-Term Liabilities $5.950M $5.874M $3.371M
YoY Change 75.31% 74.25% 8.39%
LONG-TERM LIABILITIES
Long-Term Debt $57.00K $81.00K $329.0K
YoY Change -78.73% -75.38% -85.57%
Other Long-Term Liabilities $0.00 $0.00 $454.0K
YoY Change -100.0% -100.0% -60.86%
Total Long-Term Liabilities $57.00K $81.00K $783.0K
YoY Change -89.37% -89.66% -77.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.950M $5.874M $3.371M
Total Long-Term Liabilities $57.00K $81.00K $783.0K
Total Liabilities $6.007M $5.955M $4.154M
YoY Change 52.85% 43.36% -36.68%
SHAREHOLDERS EQUITY
Retained Earnings -$19.11M -$17.77M
YoY Change 41.28%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.00K $40.00K
YoY Change 0.0%
Treasury Stock Shares 17.48K shares 17.48K shares
Shareholders Equity $18.18M $19.53M $22.84M
YoY Change
Total Liabilities & Shareholders Equity $24.19M $25.48M $26.99M
YoY Change -11.01% -5.6% 26.24%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.344M -$2.381M $942.0K
YoY Change -425.42% -352.76% -119.96%
Depreciation, Depletion And Amortization $120.0K $124.0K $133.0K
YoY Change -6.98% -6.77% -16.87%
Cash From Operating Activities -$1.975M -$2.221M -$759.0K
YoY Change -20.68% 192.62% -69.4%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$14.00K
YoY Change -100.0% -28.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.00K -$14.00K
YoY Change -100.0% -28.57% 40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.823M -62.00K -59.00K
YoY Change -3243.1% 5.08% -101.54%
NET CHANGE
Cash From Operating Activities -1.975M -2.221M -759.0K
Cash From Investing Activities 0.000 -10.00K -14.00K
Cash From Financing Activities 1.823M -62.00K -59.00K
Net Change In Cash -152.0K -2.293M -832.0K
YoY Change -94.17% 175.6% -161.63%
FREE CASH FLOW
Cash From Operating Activities -$1.975M -$2.221M -$759.0K
Capital Expenditures $0.00 -$10.00K -$14.00K
Free Cash Flow -$1.975M -$2.211M -$745.0K
YoY Change -18.82% 196.78% -69.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001622345
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
usd
POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
usd
POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
POLA Proceeds From Sale Of Common Stock Net Of Offering Costs
ProceedsFromSaleOfCommonStockNetOfOfferingCosts
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
POLA Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised And Forfeited And Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedAndForfeitedAndExpired
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise And Forfeited And Expired Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExerciseAndForfeitedAndExpiredPrice
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37960
dei Entity Registrant Name
EntityRegistrantName
POLAR POWER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0479020
dei Entity Address Address Line1
EntityAddressAddressLine1
249 E. Gardena Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Gardena
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90248
dei City Area Code
CityAreaCode
(310)
dei Local Phone Number
LocalPhoneNumber
830-9153
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Inventory Net
InventoryNet
15625000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9017000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4328000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4006000 usd
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
POLA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12949550 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
363000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5101000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1216000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4243000 usd
CY2022Q3 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2021Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
24319000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
25154000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
411000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
914000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
657000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1019000 usd
CY2022Q3 us-gaap Deposit Assets
DepositAssets
93000 usd
CY2021Q4 us-gaap Deposit Assets
DepositAssets
93000 usd
CY2022Q3 us-gaap Assets
Assets
25480000 usd
CY2021Q4 us-gaap Assets
Assets
27180000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
425000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
328000 usd
CY2022Q3 us-gaap Deposits
Deposits
3569000 usd
CY2021Q4 us-gaap Deposits
Deposits
897000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1179000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1206000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
453000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
721000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
248000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
242000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5874000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3394000 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
81000 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
268000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
268000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
5955000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3930000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12967027 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12949550 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12805680 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12788203 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37331000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36816000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17767000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13527000 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
17477 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
17477 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
40000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
40000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23250000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25480000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27180000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4136000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12273000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1954000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3170000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7971000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10398000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-247000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
966000 usd
us-gaap Gross Profit
GrossProfit
1719000 usd
us-gaap Gross Profit
GrossProfit
1875000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
328000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
372000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1134000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1119000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
319000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
533000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1145000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1485000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1482000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
823000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3648000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2796000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2129000 usd
us-gaap Interest Expense
InterestExpense
39000 usd
us-gaap Interest Expense
InterestExpense
46000 usd
CY2021Q3 POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
1715000 usd
POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
1715000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1728000 usd
us-gaap Operating Expenses
OperatingExpenses
5927000 usd
us-gaap Operating Expenses
OperatingExpenses
5400000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2376000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-762000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4208000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3525000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
12000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
14000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1704000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1698000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2381000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
942000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1827000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12848466 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12788203 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12967027 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12697683 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12848466 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12807361 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12967027 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12697683 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21391000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
515000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2381000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23250000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
515000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21895000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
942000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22837000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11491000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11491000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12466000 usd
POLA Stock Issued During Period Values Common Stock Issued Upon Exercise Of Warrants
StockIssuedDuringPeriodValuesCommonStockIssuedUponExerciseOfWarrants
707000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1827000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1827000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22837000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22837000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1827000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
387000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
420000 usd
POLA Gain On Forgiveness Of Loan Payable
GainOnForgivenessOfLoanPayable
1715000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
515000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3027000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2330000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6608000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-496000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
322000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3758000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1570000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
503000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
484000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2672000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
260000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-27000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
110000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-536000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-498000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4532000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6890000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14000 usd
POLA Proceeds From Sale Of Common Stock Net Of Offering Costs
ProceedsFromSaleOfCommonStockNetOfOfferingCosts
12466000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
707000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
181000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
209000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-181000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12964000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4738000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6060000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5101000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1646000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
363000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7706000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4532000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
363000 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
2920000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
CY2022Q3 POLA Working Capital
WorkingCapital
18445000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_z3Y3ke44zqu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory reserves and returns, impairment analysis of long-term assets, valuation allowance on deferred tax assets, income tax accruals, accruals for potential liabilities and warranty reserves and assumptions made in valuing equity instruments issued for services. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4136000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12273000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4136000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12273000 usd
POLA Cumulative Inventory Writedowns
CumulativeInventoryWritedowns
3133000 usd
CY2021 POLA Cumulative Inventory Writedowns
CumulativeInventoryWritedowns
3500000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
11516000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6607000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4109000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2410000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
15625000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
9017000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
406000 usd
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
658000 usd
POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
406000 usd
CY2021 POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
658000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z65AHb46UEh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash</i>. The Company maintains cash balances at four banks, with the majority held at one bank located in the U.S. At times, the amount on deposit exceeds the federally insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash denominated in Australian Dollars with a U.S. Dollar equivalent of $<span id="xdx_905_eus-gaap--Cash_iI_pn3n3_c20220930__srt--StatementGeographicalAxis__country--AU_zSZyfd4QUePl" title="Cash">10</span> and $<span id="xdx_900_eus-gaap--Cash_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__country--AU_zSqKdo1FMrx1" title="Cash">9</span> at September 30, 2022 and December 31, 2021, respectively, was held in an account at a financial institution located in Australia. Cash denominated in Romanian Leu with a U.S. Dollar equivalent of $<span id="xdx_903_eus-gaap--Cash_iI_pn3n3_c20220930__srt--StatementGeographicalAxis__custom--RONMember_zZhse280zQr1" title="Cash">19</span> and $<span id="xdx_903_eus-gaap--Cash_iI_pn3n3_c20211231__srt--StatementGeographicalAxis__custom--RONMember_zchhlGUlncfc" title="Cash">23</span> at September 30, 2022 and December 31, 2021, respectively, was held in an account at a financial institution located in Romania.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues. </i>For the three months ended September 30, 2022, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHmLLcFaWja4" title="Concentration risk">87%</span> of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S. For the three months ended September 30, 2021, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpiFEIuduzxg" title="Concentration risk">70%</span> of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S. There was no other revenue from customers in excess of 10% of revenues in either period. For the three months ended September 30, 2022 and September 30, 2021, sales to telecommunications customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zzZ0PEU3BWN2" title="Concentration risk">90%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zq7xVoLJNKBc" title="Concentration risk">92%</span> of total revenues, respectively. For the three months ended September 30, 2022 and September 30, 2021, sales to international customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z38dM5BiSdQj" title="Concentration risk">7%</span> and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z7cz9RGJfgBi" title="Concentration risk">12%</span>, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2022, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S., accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUy1dCY709a7" title="Concentration risk">88%</span> of total revenues. For the same period in 2021, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carriers in the U.S., accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zi3EuiIZSjxe" title="Concentration risk">67%</span>. There was no other revenue from customers in excess of 10% of revenues in either period. For the nine months ended September 30, 2022 and September 30, 2021, sales to telecommunications customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z5W1biL4cDHf" title="Concentration risk">97%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zdSIqKaIhZJ3" title="Concentration risk">90%</span> of total revenues, respectively. For the nine months ended September 30, 2022 and September 30, 2021, sales to international customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zprH9z4khS21" title="Concentration risk">2%</span> and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zjCsPMH6GHDf" title="Concentration risk">10%</span>, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At September 30, 2022, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zemWaa25rPI6" title="Concentration risk">96%</span> of the Company’s accounts receivable were from the Company’s largest customer. At December 31, 2021, the Company’s two largest receivable accounts represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zQgRMPbe4Ry6" title="Concentration risk">74%</span> and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdnJ6eiY0Fu5" title="Concentration risk">15%</span> of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of September 30, 2022 or December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. At September 30, 2022, accounts payable to the Company’s three largest vendors represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z5gB8umlAAhj" title="Concentration risk">32%</span>, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFpj9kuZRk5d" title="Concentration risk">26%</span> and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJVsKfRGQBy" title="Concentration risk">10%</span>, of the Company’s accounts payable. On December 31, 2021, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z1dSdpwCVd0b" title="Concentration risk">16%</span>, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGuQjCbMRZnl" title="Concentration risk">9%</span>, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJNDya1MYmEb" title="Concentration risk">9%</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4304000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4278000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3647000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3259000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
657000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1019000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
134000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
119000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
129000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
387000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
420000 usd
us-gaap Depreciation
Depreciation
374000 usd
us-gaap Depreciation
Depreciation
402000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
329000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
510000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
248000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
242000 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
81000 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
268000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
515000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
515000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
140000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.22
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
140000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
140000 shares
CY2022Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122000 shares
CY2021Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122 shares
CY2022Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2022Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2022Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
3.13
CY2021Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2022Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.13
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.13
POLA Description Of Warrant Expiration Date
DescriptionOfWarrantExpirationDate
expire in July 2025.
CY2021 POLA Description Of Warrant Expiration Date
DescriptionOfWarrantExpirationDate
expire in July 2025.
us-gaap Operating Lease Cost
OperatingLeaseCost
525000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
525000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
525000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
525000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M12D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0375 pure
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0375 pure
CY2021Q3 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
1749000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
411000 usd
CY2022Q3 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
2406000 usd
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1079000 usd
CY2022Q3 POLA Shortterm Operating Lease Liabilities
ShorttermOperatingLeaseLiabilities
453000 usd
CY2021Q3 POLA Shortterm Operating Lease Liabilities
ShorttermOperatingLeaseLiabilities
708000 usd
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
454000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
453000 usd
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1162000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
189000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
280000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
469000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
453000 usd
us-gaap Payments For Rent
PaymentsForRent
726000 usd
us-gaap Payments For Rent
PaymentsForRent
678000 usd
POLA Employee Retention Credits Wages Percentage
EmployeeRetentionCreditsWagesPercentage
0.70 pure
POLA Employee Retention Credits Per Shares
EmployeeRetentionCreditsPerShares
7
CY2022Q3 POLA Expenses Of Employee Retention Credit
ExpensesOfEmployeeRetentionCredit
2000000 usd
CY2022Q3 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2021Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd

Files In Submission

Name View Source Status
0001493152-22-032038-index-headers.html Edgar Link pending
0001493152-22-032038-index.html Edgar Link pending
0001493152-22-032038.txt Edgar Link pending
0001493152-22-032038-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pola-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pola-20220930_cal.xml Edgar Link unprocessable
pola-20220930_def.xml Edgar Link unprocessable
pola-20220930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pola-20220930_lab.xml Edgar Link unprocessable